加载页面时好像出了点问题.
我们的团队已经注意到了，但如果问题仍然存在，请使用电子邮件支持小工具联系我们。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 1.9x - 2.1x | 2.0x |
| Selected Fwd Revenue Multiple | 1.4x - 1.6x | 1.5x |
| Fair Value | 55.83﷼ - 61.70﷼ | 58.76﷼ |
| Upside | 33.4% - 47.4% | 40.4% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Canadian General Medical Center Complex Company | 9518 | SASE:9518 |
| Alf Meem Yaa for Medical Supplies and Equipment Company | 9527 | SASE:9527 |
| Dallah Healthcare Company | 4004 | SASE:4004 |
| Saudi Chemical Holding Company | 2230 | SASE:2230 |
| Al-Modawat Specialized Medical Company | 9594 | SASE:9594 |
| Scientific and Medical Equipment House Company | 4014 | SASE:4014 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| 9518 | 9527 | 4004 | 2230 | 9594 | 4014 | |||
| SASE:9518 | SASE:9527 | SASE:4004 | SASE:2230 | SASE:9594 | SASE:4014 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | NM- | NM- | 20.7% | 16.7% | NM- | 8.0% | ||
| 3Y CAGR | 16.0% | 22.5% | 15.0% | 23.2% | NM- | 7.8% | ||
| Latest Twelve Months | 21.5% | 15.4% | 8.9% | 31.3% | 5.7% | 9.8% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 20.3% | 17.2% | 15.9% | 5.2% | 21.7% | 8.9% | ||
| Prior Fiscal Year | 21.0% | 15.4% | 17.2% | 6.5% | 20.7% | 8.3% | ||
| Latest Fiscal Year | 15.5% | 16.5% | 17.7% | 6.8% | 29.4% | 4.5% | ||
| Latest Twelve Months | 10.5% | 17.3% | 17.7% | 6.8% | 19.0% | 4.5% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 4.65x | 4.14x | 4.01x | 1.37x | 5.10x | 1.54x | ||
| EV / LTM EBIT | 44.4x | 23.9x | 22.7x | 20.2x | 26.8x | 34.5x | ||
| Price / LTM Sales | 5.00x | 4.17x | 3.84x | 1.14x | 5.25x | 1.43x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 1.37x | 4.14x | 5.10x | |||||
| Historical EV / LTM Revenue | 1.54x | 1.99x | 2.38x | |||||
| Selected EV / LTM Revenue | 1.92x | 2.02x | 2.12x | |||||
| (x) LTM Revenue | 877 | 877 | 877 | |||||
| (=) Implied Enterprise Value | 1,686 | 1,775 | 1,864 | |||||
| (-) Non-shareholder Claims * | 0 | 0 | 0 | |||||
| (=) Equity Value | 1,686 | 1,775 | 1,864 | |||||
| (/) Shares Outstanding | 30.0 | 30.0 | 30.0 | |||||
| Implied Value Range | 56.21 | 59.17 | 62.12 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 56.21 | 59.17 | 62.12 | 41.85 | ||||
| Upside / (Downside) | 34.3% | 41.4% | 48.4% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 9518 | 9527 | 4004 | 2230 | 9594 | 4014 | |
| Enterprise Value | 494 | 980 | 12,847 | 8,760 | 379 | 1,256 | |
| (+) Cash & Short Term Investments | 45 | 9 | 166 | 130 | 25 | 0 | |
| (+) Investments & Other | 0 | 0 | 1,607 | 2 | 0 | 0 | |
| (-) Debt | (8) | (2) | (2,023) | (1,587) | (13) | 0 | |
| (-) Other Liabilities | 0 | 0 | (278) | (12) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 532 | 987 | 12,319 | 7,294 | 391 | 1,256 | |
| (/) Shares Outstanding | 77.0 | 7.0 | 97.3 | 843.2 | 23.8 | 30.0 | |
| Implied Stock Price | 6.91 | 141.00 | 126.60 | 8.65 | 16.46 | 41.85 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 6.91 | 141.00 | 126.60 | 8.65 | 16.46 | 41.85 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |